PortfoliosLab logo
IDXX vs. ZTS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IDXX and ZTS is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

IDXX vs. ZTS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IDEXX Laboratories, Inc. (IDXX) and Zoetis Inc. (ZTS). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

IDXX:

0.00

ZTS:

-0.04

Sortino Ratio

IDXX:

0.23

ZTS:

0.05

Omega Ratio

IDXX:

1.03

ZTS:

1.01

Calmar Ratio

IDXX:

-0.01

ZTS:

-0.06

Martin Ratio

IDXX:

-0.02

ZTS:

-0.19

Ulcer Index

IDXX:

13.35%

ZTS:

12.05%

Daily Std Dev

IDXX:

32.15%

ZTS:

25.85%

Max Drawdown

IDXX:

-81.46%

ZTS:

-46.52%

Current Drawdown

IDXX:

-26.82%

ZTS:

-30.46%

Fundamentals

Market Cap

IDXX:

$40.34B

ZTS:

$72.38B

EPS

IDXX:

$10.83

ZTS:

$5.58

PE Ratio

IDXX:

46.31

ZTS:

29.14

PEG Ratio

IDXX:

4.14

ZTS:

2.77

PS Ratio

IDXX:

10.26

ZTS:

7.79

PB Ratio

IDXX:

27.86

ZTS:

15.55

Total Revenue (TTM)

IDXX:

$3.93B

ZTS:

$9.29B

Gross Profit (TTM)

IDXX:

$2.41B

ZTS:

$6.52B

EBITDA (TTM)

IDXX:

$1.29B

ZTS:

$3.98B

Returns By Period

In the year-to-date period, IDXX achieves a 24.93% return, which is significantly higher than ZTS's 2.70% return. Over the past 10 years, IDXX has outperformed ZTS with an annualized return of 22.51%, while ZTS has yielded a comparatively lower 13.67% annualized return.


IDXX

YTD

24.93%

1M

18.07%

6M

23.77%

1Y

0.00%

3Y*

9.02%

5Y*

11.03%

10Y*

22.51%

ZTS

YTD

2.70%

1M

8.33%

6M

-4.76%

1Y

-1.14%

3Y*

-0.17%

5Y*

4.63%

10Y*

13.67%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


IDEXX Laboratories, Inc.

Zoetis Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

IDXX vs. ZTS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDXX
The Risk-Adjusted Performance Rank of IDXX is 4848
Overall Rank
The Sharpe Ratio Rank of IDXX is 5050
Sharpe Ratio Rank
The Sortino Ratio Rank of IDXX is 4444
Sortino Ratio Rank
The Omega Ratio Rank of IDXX is 4343
Omega Ratio Rank
The Calmar Ratio Rank of IDXX is 5151
Calmar Ratio Rank
The Martin Ratio Rank of IDXX is 5151
Martin Ratio Rank

ZTS
The Risk-Adjusted Performance Rank of ZTS is 4444
Overall Rank
The Sharpe Ratio Rank of ZTS is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of ZTS is 3838
Sortino Ratio Rank
The Omega Ratio Rank of ZTS is 3838
Omega Ratio Rank
The Calmar Ratio Rank of ZTS is 4848
Calmar Ratio Rank
The Martin Ratio Rank of ZTS is 4848
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IDXX vs. ZTS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for IDEXX Laboratories, Inc. (IDXX) and Zoetis Inc. (ZTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current IDXX Sharpe Ratio is 0.00, which is higher than the ZTS Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of IDXX and ZTS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

IDXX vs. ZTS - Dividend Comparison

IDXX has not paid dividends to shareholders, while ZTS's dividend yield for the trailing twelve months is around 1.12%.


TTM20242023202220212020201920182017201620152014
IDXX
IDEXX Laboratories, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ZTS
Zoetis Inc.
1.12%1.06%0.76%0.89%0.41%0.48%0.50%0.59%0.58%0.71%0.69%0.67%

Drawdowns

IDXX vs. ZTS - Drawdown Comparison

The maximum IDXX drawdown since its inception was -81.46%, which is greater than ZTS's maximum drawdown of -46.52%. Use the drawdown chart below to compare losses from any high point for IDXX and ZTS.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

IDXX vs. ZTS - Volatility Comparison

IDEXX Laboratories, Inc. (IDXX) and Zoetis Inc. (ZTS) have volatilities of 10.56% and 10.13%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

IDXX vs. ZTS - Financials Comparison

This section allows you to compare key financial metrics between IDEXX Laboratories, Inc. and Zoetis Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B1.50B2.00B20212022202320242025
998.43M
2.22B
(IDXX) Total Revenue
(ZTS) Total Revenue
Values in USD except per share items

IDXX vs. ZTS - Profitability Comparison

The chart below illustrates the profitability comparison between IDEXX Laboratories, Inc. and Zoetis Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%20212022202320242025
62.4%
72.0%
(IDXX) Gross Margin
(ZTS) Gross Margin
IDXX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, IDEXX Laboratories, Inc. reported a gross profit of 623.38M and revenue of 998.43M. Therefore, the gross margin over that period was 62.4%.

ZTS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Zoetis Inc. reported a gross profit of 1.60B and revenue of 2.22B. Therefore, the gross margin over that period was 72.0%.

IDXX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, IDEXX Laboratories, Inc. reported an operating income of 316.53M and revenue of 998.43M, resulting in an operating margin of 31.7%.

ZTS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Zoetis Inc. reported an operating income of 846.00M and revenue of 2.22B, resulting in an operating margin of 38.1%.

IDXX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, IDEXX Laboratories, Inc. reported a net income of 242.68M and revenue of 998.43M, resulting in a net margin of 24.3%.

ZTS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Zoetis Inc. reported a net income of 631.00M and revenue of 2.22B, resulting in a net margin of 28.4%.